Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalfampridine ER for Ambulatory Activity in MS
NCT01356940Phase 4Completed
- Sponsor
- Theodore R. Brown
- Start
- Nov 2010
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dalfampridine in multiple sclerosis (MS), sponsored by Theodore R. Brown. Started Nov 2010; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01356940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01356940.